Feed aggregator

Convicted ‘Pharma Bro’ Shkreli's Vyera Files for Bankruptcy

Biospace news - Sun, 11/05/2023 - 02:00
Convicted ‘Pharma Bro’ Shkreli's Vyera Files for Bankruptcy 5/11/2023

Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Committee

Biospace news - Sun, 11/05/2023 - 02:00
Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Committee 5/11/2023

Gout Disease Control Suffered After FDA-Driven Price Hike: Study

Biospace news - Sun, 11/05/2023 - 02:00
Gout Disease Control Suffered After FDA-Driven Price Hike: Study 5/11/2023

What You Need to Know to Launch a Biotech Startup

Biospace news - Sun, 11/05/2023 - 02:00
What You Need to Know to Launch a Biotech Startup 5/11/2023

FDA Approves First Drug for Agitation in Alzheimer's Dementia: Update

Biospace news - Sun, 11/05/2023 - 02:00
FDA Approves First Drug for Agitation in Alzheimer's Dementia: Update 5/11/2023

Moving from Tech to Biotech: Benefits, Challenges & Advice from Experts

Biospace news - Sat, 11/04/2023 - 02:00
Moving from Tech to Biotech: Benefits, Challenges & Advice from Experts 4/11/2023

HI-Bio Advances Rare Kidney Disease Therapy to Late-Stage Studies

Biospace news - Sat, 11/04/2023 - 02:00
HI-Bio Advances Rare Kidney Disease Therapy to Late-Stage Studies 4/11/2023

A New Era: Treating Negative Symptoms in Schizophrenia

Biospace news - Sat, 11/04/2023 - 02:00
A New Era: Treating Negative Symptoms in Schizophrenia 4/11/2023

Metabolite tells cells whether to repair DNA

World Pharma News - Fri, 11/03/2023 - 11:00
Metabolites called nucleotides are the building blocks of DNA and can impact cancer's sensitivity or resistance to chemotherapy and radiation in brain cancer.

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite, called GTP, controls responses to radiation and chemotherapy in an unexpected way.

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

Biospace news - Fri, 11/03/2023 - 02:00
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up 11/3/2023

Lexeo Therapeutics Launches $100M IPO to Fund Cardio, Alzheimer’s Candidates

Biospace news - Fri, 11/03/2023 - 02:00
Lexeo Therapeutics Launches $100M IPO to Fund Cardio, Alzheimer’s Candidates 11/3/2023

Regeneron’s Eylea Sales Decline in Q3, Battle with Roche’s Vabysmo Heats Up

Biospace news - Fri, 11/03/2023 - 02:00
Regeneron’s Eylea Sales Decline in Q3, Battle with Roche’s Vabysmo Heats Up 11/3/2023

Neurocrine Touts Phase III Huntington’s Data, Posts 29% YoY Growth

Biospace news - Fri, 11/03/2023 - 02:00
Neurocrine Touts Phase III Huntington’s Data, Posts 29% YoY Growth 11/3/2023

Confidence and Caution as AI Predicts Drug Safety

Biospace news - Fri, 11/03/2023 - 02:00
Confidence and Caution as AI Predicts Drug Safety 11/3/2023

HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit

Biospace news - Fri, 11/03/2023 - 02:00
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit 11/3/2023

Novel Immune Modulator Has Potential to Change Treatment Approach in Rheumatoid Arthritis and Ulc...

Biospace news - Fri, 11/03/2023 - 02:00
Novel Immune Modulator Has Potential to Change Treatment Approach in Rheumatoid Arthritis and Ulc... 11/3/2023

Bayer and Broad Institute of MIT and Harvard extend research collaboration to develop new cancer therapies

World Pharma News - Thu, 11/02/2023 - 11:00
Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their research collaboration of 10 years by an additional five years, to develop and advance innovative cancer treatments. The expanded agreement will focus on joint cancer target identification and discovery of new therapeutic approaches in oncology.

Novo Logs Over 700% Wegovy Sales Growth in Q3, Raises 2023 Outlook

Biospace news - Thu, 11/02/2023 - 02:00
Novo Logs Over 700% Wegovy Sales Growth in Q3, Raises 2023 Outlook 11/2/2023

Lilly’s Mounjaro Beats Q3 Expectations, But Company Cuts Full-Year Profit Guidance

Biospace news - Thu, 11/02/2023 - 02:00
Lilly’s Mounjaro Beats Q3 Expectations, But Company Cuts Full-Year Profit Guidance 11/2/2023

Moderna Posts Q3 Loss, Takes $1.3B in Write-Downs on COVID-19 Shots

Biospace news - Thu, 11/02/2023 - 02:00
Moderna Posts Q3 Loss, Takes $1.3B in Write-Downs on COVID-19 Shots 11/2/2023